Share this

Press Releases


Press Release: NVHR and CHLPI Release New Analysis Showing State Policies Limit Progress Towards Hepatitis C Elimination in the U.S. 
November 13, 2020

New York Increases Access to Hepatitis C Treatment for Medicaid Patients
September 21, 2020

Press Release: NVHR Applauds Hep Free Hawai`i for Landmark Hepatitis Elimination Strategy
July 29, 2020

Press Release: Iowa Lifts Barrier to Accessing Hepatitis C Treatment, but Some Discriminatory Restrictions Remain
July 01, 2020

Press Release: NVHR Announces New Advisory Committee and Policy Manager to Elevate NVHR Member Voices and Provide Strategic Direction for the Organization - July 16, 2020

Press Release: NVHR and HEP Statement on Administration Rule Reducing Protections for Transgender Patients June 15, 2020

Press Release: Ohio Lifts Discriminatory Barriers to Accessing Hepatitis C Treatment - May 21, 2020

Press Release: NVHR Applauds Latest Guidance from the USPSTF Recommending Hepatitis C Screening for all U.S. Adults - 4-9-2020

Your help needed TODAY: Ask Congress to Support Frontline Public Health Programs Helping Underserved Populations - April 2, 2020

How can you use your voice to drive viral hepatitis advocacy? Tune in Monday March 23rd at 2pm ET/11am PT to learn from media experts. The webinar training will include tangible strategies for sharing your voice through both digital advocacy (e.g. social media, emails to legislators, engagement with large organizations) and traditional media (e.g letters to the editor & op-eds) routes of communication.

Press Release: Support Increased FY 2021 Funding for Viral Hepatitis - Mar 17, 2020

State of Hep C MT Removal Release - Montana Removes Discriminatory Restrictions on Access to Hepatitis C Treatment - Feb 3, 2020

NVHR Applauds CDC and HHS For Funding Programs to End HIV and Viral Hepatitis Epidemics - Jan 31, 2020

NVHR Applauds the National Academies of Sciences, Engineering, and Medicine (NASEM) for Calling for an Integrated Response to Treat Opioid Use Disorder and Infectious Disease Epidemics - Jan 23, 2020





Press Release: NVHR and CHLPI: October 9, 2019

Sign-on Letter to CMS, October 9, 2019



NVHR Press Release: President's Budget Fails to Address Severity of Viral Hepatitis Epidemic February 10, 2016


Press Release: Science, Not Stigma Must Drive Hepatitis C Treatment Decisions, November 13, 2015

Coalition for Syringe Access Press Release: Congressional Briefings Tout Benefits, Debunk Myths of Syringe Services Programs October 30, 2015

Community Advocates Applaud U.S. Representatives' Call for Leadership, Resources to Combat Deadly Epidemics on World Hepatitis Day July 27, 2015


NVHR Statement on Express Scripts/AbbVie Hepatitis C Treatment Access Announcement December 22, 2014

Community Leaders Call For End to Hepatitis C Treatment Access Crisis September 20, 2014



NVHR In the News


We Can’t Eliminate Hepatitis C Without Removing Barriers to Treatment - Nov. 14, 2020 

To progress toward eliminating this disabling and deadly disease, the U.S. must eliminate Medicaid restrictions on hepatitis C treatment and educate providers about ongoing stigma that disenfranchises certain communities.


State Policies Create Barriers to Hepatitis C Elimination - Nov. 13, 2020

Requiring sobriety prior to treatment and curtailing harm reduction hinder efforts to eliminate hep C.


Consider the Unintended Consequences on Patient CareOct. 15, 2020

NVHR's Adrienne Simmons was published in Hep Magazine advocating for CMS to delay a proposed Medicaid rule change that could negatively impact hepatitis patients.

New State Regulations Expand Access to Hepatitis C Treatments - Oct. 8, 2020

Dr. Adrienne Simmons, Pharmacist and Policy Manager at the National Viral Hepatitis Roundtable and Annette Gaudino, Director of Policy Strategy at the Treatment Action Group speak with WCNY's Capitol Pressroom about the removal of prior authorization requirements for hepatitis C treatment for NY Medicaid beneficiaries. Listen here.


NVHR and HEP Statement on Systemic Racism and Inequalities Facing Black Communities - June 3, 2020

Opinion: Hepatitis C is a curable disease. Texans shouldn’t have to wait for a cure Statesmen, March 7, 2020


“It's Destroyed People's Lives”: The Shocking Rise in Hepatitis C-Related Deaths, Broadly, June 16, 2016

Report: Number of hepatitis C-linked deaths at record high, Pocono Record, May 18, 2016

It’s Time to End Insurance Restrictions on Life-Saving Hepatitis C Treatments, American Journal of Managed Care, May 3, 2016

Hepatitis C drug costs leave many without care, Boston Globe, April 9, 2016

The Link Between Hepatitis B, C, and Cancer, MediaPlanet, March 29, 2015

President's federal budget sustains HIV funding, viral hepatitis funding falls flat, The Bay Area Reporter, February 18, 2016


State Medicaid Restrictions for Hepatitis C Cures Are Creating One of America's Worst Health DisparitiesHuffington Post, December 11, 2015

Gilead expands PrEP assistance; feds call for more hep C coverageThe Bay Area Reporter, November 26, 2015

Hep C: Why doctors say all baby boomers should be tested, Chicago Tribune, October 8, 2015

White House Is Pressed to Help Widen Access to Hepatitis C Drugs via Medicaid, The New York Times, August 25, 2015

A Time to Cure: The Growing Case for New Hepatitis C Treatments, Huffington Post, August 13, 2015

The Past, Present and Future of Hepatitis C, USA Today, September 23, 2015

Discourse needed on 'culturally invisible' disease, Bloomington Herald-Times, August 19, 2015

Specialty Drug Costs: Hard Pills to Swallow, Workforce, May 24, 2015

Resolved For 2015: No More Hepatitis C, Huffington Post, January 8, 2015


One company’s battle to stop the wave of high-priced drugs, The Washington Post, December 24, 2014

Hepatitis C: The cost conundrum, The Hill, November 12, 2014

Hepatitis C patients may not qualify for pricey drugs unless illness is advanced, The Washington Post, November 4, 2014

Some Hep C Patients May Not Get Coverage for Pricey Drugs, MedPage Today, October 28, 2014

Harvoni, a Hepatitis C Drug From Gilead, Wins F.D.A. Approval, New York Times, October 10, 2014

Why Hepatitis C Still Kills 16,000 Americans Per Year, and What We Can Do About It, Huffington Post, July 28, 2014

States limit Medicaid users’ access to hepatitis drug because of cost, Delaware Online, July 28, 2014

Sovaldi Debate Continues: Will Medicaid And Insurance Companies Approve This High Cost Cure For Hepatitis C Patients?, Medical Daily, July 24, 2014

Patient Cures Spur Demand for $1,000 Hepatitis C Pill, Bloomberg, July 24, 2014

New hepatitis C drugs’ price prompts an ethical debate: Who deserves to get them?, The Washington Post, May 2, 2014

Medicare Eases Restrictions On Pricey Hepatitis C Treatment, NPR, May 16, 2014

Medicare Won't Always Pay For Boomers' Pricey Hepatitis C Drugs, NPR, May 12, 2014

Healthier Patients May Have To Wait For Costly Hepatitis C Drugs, NPR, May 12, 2014

Costly hepatitis C drug worries insurers, patients, Tampa Bay Times, March 23, 2014